ms ADINA LASSER

-Alzheimer's Screening & Prevention Act (ASAP) H.R. 6130/ S. 3267 -Lowering Costs for Caregivers Act (S. 1565/H.R. 138) -Federal vaccine messaging -Impacts of IRA on Older Americans -National Institutes of Health advance funding of multi-year research grants -Clinical Trials Modernization Act H.R.7905 -Patient Access to Cancer and Complex Therapies Act H.R. 4299 -Diabetes Foot Health and Modernization Access Act H.R. 7905 -Oppose PBM Kickbacks H.R. 7895 -Oppose Codification of MFN Drug Pricing Proposals (no bill) -Message support for Rare Disease Clinical Trials Improvements

-Alzheimer's Screening & Prevention Act (ASAP) H.R. 6130/ S. 3267 -Lowering Costs for Caregivers Act (S. 1565/H.R. 138) -Federal vaccine messaging -Impacts of IRA on Older Americans -National Institutes of Health advance funding of multi-year research grants -Clinical Trials Modernization Act H.R.7905 -Patient Access to Cancer and Complex Therapies Act H.R. 4299 -Diabetes Foot Health and Modernization Access Act H.R. 7905 -Oppose PBM Kickbacks H.R. 7895 -Oppose Codification of MFN Drug Pricing Proposals (no bill) -End Coverage with Evidence Development for Alzheimer's medications and Trans Catheter Aortic Valve Replacement

-Alzheimer's Screening & Prevention Act (ASAP) H.R. 6130/ S. 3267 -Lowering Costs for Caregivers Act (S. 1565/H.R. 138) -Federal vaccine messaging -Impacts of IRA on Older Americans -National Institutes of Health advance funding of multi-year research grants -Clinical Trials Modernization Act H.R.7905 -Patient Access to Cancer and Complex Therapies Act H.R. 4299 -Diabetes Foot Health and Modernization Access Act H.R. 7905 -Oppose PBM Kickbacks H.R. 7895 -Oppose Codification of MFN Drug Pricing Proposals (no bill) -End Coverage with Evidence Development for Alzheimer's medications and Trans Catheter Aortic Valve Replacement

-Alzheimer's Screening & Prevention Act (ASAP) H.R. 6130/ S. 3267 -Lowering Costs for Caregivers Act (S. 1565/H.R. 138) -Federal vaccine messaging -Impacts of IRA on Older Americans -National Institutes of Health advance funding of multi-year research grants -Clinical Trials Modernization Act H.R.7905 -Patient Access to Cancer and Complex Therapies Act H.R. 4299 -Diabetes Foot Health and Modernization Access Act H.R. 7905 -Oppose PBM Kickbacks H.R. 7895 -Oppose Codification of MFN Drug Pricing Proposals (no bill) -Message support for Rare Disease Clinical Trials Improvements

-Alzheimer's Screening & Prevention Act (ASAP) H.R. 6130/ S. 3267 -Lowering Costs for Caregivers Act (S. 1565/H.R. 138) -Federal vaccine messaging -Impacts of IRA on Older Americans -National Institutes of Health advance funding of multi-year research grants -Clinical Trials Modernization Act H.R.7905 -Patient Access to Cancer and Complex Therapies Act H.R. 4299 -Diabetes Foot Health and Modernization Access Act H.R. 7905 -Oppose PBM Kickbacks H.R. 7895 -Oppose Codification of MFN Drug Pricing Proposals (no bill) -End Coverage with Evidence Development for Alzheimer's medications and Trans Catheter Aortic Valve Replacement

-Alzheimer's Screening & Prevention Act (ASAP) H.R. 6130/ S. 3267 -Lowering Costs for Caregivers Act (S. 1565/H.R. 138) -Federal vaccine messaging -Impacts of IRA on Older Americans -National Institutes of Health advance funding of multi-year research grants -Clinical Trials Modernization Act H.R.7905 -Patient Access to Cancer and Complex Therapies Act H.R. 4299 -Diabetes Foot Health and Modernization Access Act H.R. 7905 -Oppose PBM Kickbacks H.R. 7895 -Oppose Codification of MFN Drug Pricing Proposals (no bill) -End Coverage with Evidence Development for Alzheimer's medications and Trans Catheter Aortic Valve Replacement

-Alzheimer's Screening & Prevention Act (ASAP) H.R. 6130/ S. 3267 -Lowering Costs for Caregivers Act (S. 1565/H.R. 138) -Federal vaccine messaging -Impacts of IRA on Older Americans -National Institutes of Health advance funding of multi-year research grants

-Implementation of Medicare Part D beneficiary affordability provisions -Nursing home quality measures -Implementation of the Medicare Direct Negotiation Program and its impact on older adults -Utilization management reform in Medicare -Increasing Medication Access for Seniors Act (H.R.6401)

-Implementation of Medicare Part D beneficiary affordability provisions -Nursing home quality measures -Implementation of the Medicare Direct Negotiation Program and its impact on older adults -Utilization management reform in Medicare -Increasing Medication Access for Seniors Act (H.R.6401)

-Implementation of Medicare Part D beneficiary affordability provisions -Nursing home quality measures -Implementation of the Medicare Direct Negotiation Program and its impact on older adults -Utilization management reform in Medicare -Increasing Medication Access for Seniors Act (H.R.6401) -End Coverage with Evidence Development for Alzheimer's Medications and TAVR

-Implementation of Medicare Part D beneficiary affordability provisions -Nursing home quality measures -Implementation of the Medicare Direct Negotiation Program and its impact on older adults -Utilization management reform in Medicare -Increasing Medication Access for Seniors Act (H.R.6401) -End Coverage with Evidence Development for Alzheimer's Medications and TAVR

-Alzheimer's Screening & Prevention Act (ASAP) H.R. 6130/ S. 3267 -Lowering Costs for Caregivers Act (S. 1565/H.R. 138) -Federal vaccine messaging -Impacts of IRA on Older Americans -National Institutes of Health advance funding of multi-year research grants -Clinical Trials Modernization Act H.R.7905 -Patient Access to Cancer and Complex Therapies Act H.R. 4299 -Diabetes Foot Health and Modernization Access Act H.R. 7905 -Oppose PBM Kickbacks H.R. 7895 -Oppose Codification of MFN Drug Pricing Proposals (no bill) -End Coverage with Evidence Development for Alzheimer's medications and Trans Catheter Aortic Valve Replacement

-Alzheimer's Screening & Prevention Act (ASAP) H.R. 6130/ S. 3267 -Lowering Costs for Caregivers Act (S. 1565/H.R. 138) -Federal vaccine messaging -Impacts of IRA on Older Americans -National Institutes of Health advance funding of multi-year research grants -Clinical Trials Modernization Act H.R.7905 -Patient Access to Cancer and Complex Therapies Act H.R. 4299 -Diabetes Foot Health and Modernization Access Act H.R. 7905 -Oppose PBM Kickbacks H.R. 7895 -Oppose Codification of MFN Drug Pricing Proposals (no bill) -Message support for Rare Disease Clinical Trials Improvements

-Alzheimer's Screening & Prevention Act (ASAP) H.R. 6130/ S. 3267 -Lowering Costs for Caregivers Act (S. 1565/H.R. 138) -Federal vaccine messaging -Impacts of IRA on Older Americans -National Institutes of Health advance funding of multi-year research grants -Clinical Trials Modernization Act H.R.7905 -Patient Access to Cancer and Complex Therapies Act H.R. 4299 -Diabetes Foot Health and Modernization Access Act H.R. 7905 -Oppose PBM Kickbacks H.R. 7895 -Oppose Codification of MFN Drug Pricing Proposals (no bill) -End Coverage with Evidence Development for Alzheimer's medications and Trans Catheter Aortic Valve Replacement

-Alzheimer's Screening & Prevention Act (ASAP) H.R. 6130/ S. 3267 -Lowering Costs for Caregivers Act (S. 1565/H.R. 138) -Federal vaccine messaging -Impacts of IRA on Older Americans -National Institutes of Health advance funding of multi-year research grants -Clinical Trials Modernization Act H.R.7905 -Patient Access to Cancer and Complex Therapies Act H.R. 4299 -Diabetes Foot Health and Modernization Access Act H.R. 7905 -Oppose PBM Kickbacks H.R. 7895 -Oppose Codification of MFN Drug Pricing Proposals (no bill) -End Coverage with Evidence Development for Alzheimer's medications and Trans Catheter Aortic Valve Replacement

-Alzheimer's Screening & Prevention Act (ASAP) H.R. 6130/ S. 3267 -Lowering Costs for Caregivers Act (S. 1565/H.R. 138) -Federal vaccine messaging -Impacts of IRA on Older Americans -National Institutes of Health advance funding of multi-year research grants -Clinical Trials Modernization Act H.R.7905 -Patient Access to Cancer and Complex Therapies Act H.R. 4299 -Diabetes Foot Health and Modernization Access Act H.R. 7905 -Oppose PBM Kickbacks H.R. 7895 -Oppose Codification of MFN Drug Pricing Proposals (no bill) -Message support for Rare Disease Clinical Trials Improvements

-Alzheimer's Screening & Prevention Act (ASAP) H.R. 6130/ S. 3267 -Lowering Costs for Caregivers Act (S. 1565/H.R. 138) -Federal vaccine messaging -Impacts of IRA on Older Americans -National Institutes of Health advance funding of multi-year research grants -Clinical Trials Modernization Act H.R.7905 -Patient Access to Cancer and Complex Therapies Act H.R. 4299 -Diabetes Foot Health and Modernization Access Act H.R. 7905 -Oppose PBM Kickbacks H.R. 7895 -Oppose Codification of MFN Drug Pricing Proposals (no bill) -End Coverage with Evidence Development for Alzheimer's medications and Trans Catheter Aortic Valve Replacement

-FY27 report language for the Food and Drug Administration on antipsychotics black box warning -FY27 report language for the Medicare Program antipsychotics measure -FY27 report language for the Medicare Prescription Payment Plan -FY27 report language for utilization management reform in the Medicare program -FY27 medical research funding -FY27 funding for FDA's Neurology Drug Program -FY 27 Appropriations H.R. 9260 and pending Senate bill, Increase Funding for Programs benefitting older adults at HHS, including ASPE, NIH, CDC HRSA, ARHQ, FDA, CMS, ACL

-FY27 report language for the Food and Drug Administration on antipsychotics black box warning -FY27 report language for the Medicare Program antipsychotics measure -FY27 report language for the Medicare Prescription Payment Plan -FY27 report language for utilization management reform in the Medicare program -FY27 medical research funding -FY27 funding for FDA's Neurology Drug Program -FY 27 Appropriations H.R. 9260 and pending Senate bill, Increase Funding for Programs benefitting older adults at HHS, including ASPE, NIH, CDC HRSA, ARHQ, FDA, CMS, ACL

-FY27 report language for the Food and Drug Administration on antipsychotics black box warning -FY27 report language for the Medicare Program antipsychotics measure -FY27 report language for the Medicare Prescription Payment Plan -FY27 report language for utilization management reform in the Medicare program -FY27 medical research funding -FY27 funding for FDA's Neurology Drug Program -FY 27 Appropriations H.R. 9260 and pending Senate bill, Increase Funding for Programs benefitting older adults at HHS, including ASPE, NIH, CDC HRSA, ARHQ, FDA, CMS, ACL

-Alzheimer's Screening & Prevention Act (ASAP) H.R. 6130/ S. 3267 -Lowering Costs for Caregivers Act (S. 1565/H.R. 138) -Federal vaccine messaging -Impacts of IRA on Older Americans -National Institutes of Health advance funding of multi-year research grants -Clinical Trials Modernization Act H.R.7905 -Patient Access to Cancer and Complex Therapies Act H.R. 4299 -Diabetes Foot Health and Modernization Access Act H.R. 7905 -Oppose PBM Kickbacks H.R. 7895 -Oppose Codification of MFN Drug Pricing Proposals (no bill) -Message support for Rare Disease Clinical Trials Improvements

-Alzheimer's Screening & Prevention Act (ASAP) H.R. 6130/ S. 3267 -Lowering Costs for Caregivers Act (S. 1565/H.R. 138) -Federal vaccine messaging -Impacts of IRA on Older Americans -National Institutes of Health advance funding of multi-year research grants -Clinical Trials Modernization Act H.R.7905 -Patient Access to Cancer and Complex Therapies Act H.R. 4299 -Diabetes Foot Health and Modernization Access Act H.R. 7905 -Oppose PBM Kickbacks H.R. 7895 -Oppose Codification of MFN Drug Pricing Proposals (no bill) -End Coverage with Evidence Development for Alzheimer's medications and Trans Catheter Aortic Valve Replacement

-Alzheimer's Screening & Prevention Act (ASAP) H.R. 6130/ S. 3267 -Lowering Costs for Caregivers Act (S. 1565/H.R. 138) -Federal vaccine messaging -Impacts of IRA on Older Americans -National Institutes of Health advance funding of multi-year research grants -Clinical Trials Modernization Act H.R.7905 -Patient Access to Cancer and Complex Therapies Act H.R. 4299 -Diabetes Foot Health and Modernization Access Act H.R. 7905 -Oppose PBM Kickbacks H.R. 7895 -Oppose Codification of MFN Drug Pricing Proposals (no bill) -End Coverage with Evidence Development for Alzheimer's medications and Trans Catheter Aortic Valve Replacement

-Alzheimer's Screening & Prevention Act (ASAP) H.R. 6130/ S. 3267 -Lowering Costs for Caregivers Act (S. 1565/H.R. 138) -Federal vaccine messaging -Impacts of IRA on Older Americans -National Institutes of Health advance funding of multi-year research grants

-Alzheimer's Screening & Prevention Act (ASAP) H.R. 6130/ S. 3267 -Lowering Costs for Caregivers Act (S. 1565/H.R. 138) -Federal vaccine messaging -Impacts of IRA on Older Americans -National Institutes of Health advance funding of multi-year research grants

-Alzheimer's Screening & Prevention Act (ASAP) H.R. 6130/ S. 3267 -Lowering Costs for Caregivers Act (S. 1565/H.R. 138) -Federal vaccine messaging -Impacts of IRA on Older Americans -National Institutes of Health advance funding of multi-year research grants -Clinical Trials Modernization Act H.R.7905 -Patient Access to Cancer and Complex Therapies Act H.R. 4299 -Diabetes Foot Health and Modernization Access Act H.R. 7905 -Oppose PBM Kickbacks H.R. 7895 -Oppose Codification of MFN Drug Pricing Proposals (no bill) -End Coverage with Evidence Development for Alzheimer's medications and Trans Catheter Aortic Valve Replacement

-Alzheimer's Screening & Prevention Act (ASAP) H.R. 6130/ S. 3267 -Lowering Costs for Caregivers Act (S. 1565/H.R. 138) -Federal vaccine messaging -Impacts of IRA on Older Americans -National Institutes of Health advance funding of multi-year research grants -Clinical Trials Modernization Act H.R.7905 -Patient Access to Cancer and Complex Therapies Act H.R. 4299 -Diabetes Foot Health and Modernization Access Act H.R. 7905 -Oppose PBM Kickbacks H.R. 7895 -Oppose Codification of MFN Drug Pricing Proposals (no bill) -End Coverage with Evidence Development for Alzheimer's medications and Trans Catheter Aortic Valve Replacement

-Alzheimer's Screening & Prevention Act (ASAP) H.R. 6130/ S. 3267 -Lowering Costs for Caregivers Act (S. 1565/H.R. 138) -Federal vaccine messaging -Impacts of IRA on Older Americans -National Institutes of Health advance funding of multi-year research grants -Clinical Trials Modernization Act H.R.7905 -Patient Access to Cancer and Complex Therapies Act H.R. 4299 -Diabetes Foot Health and Modernization Access Act H.R. 7905 -Oppose PBM Kickbacks H.R. 7895 -Oppose Codification of MFN Drug Pricing Proposals (no bill) -Message support for Rare Disease Clinical Trials Improvements

-H.R. 3701 the Family Vaccine Protection Act -Food and Drug Administration's Covid Vaccine Schedule Framework -Department of Health and Human Services' Reorganization -H.R. 1 the One Big Beautiful Bill Act -H.R.3164 - Ensuring Community Access to Pharmacist Services Act -Older Americans Act

-H.R. 3701 the Family Vaccine Protection Act -Food and Drug Administration's Covid Vaccine Schedule Framework -Department of Health and Human Services' Reorganization -H.R. 1 the One Big Beautiful Bill Act -H.R.3164 - Ensuring Community Access to Pharmacist Services Act -Older Americans Act

-H.R. 3701 the Family Vaccine Protection Act -Food and Drug Administration's Covid Vaccine Schedule Framework -Department of Health and Human Services' Reorganization -H.R. 1 the One Big Beautiful Bill Act -H.R.3164 - Ensuring Community Access to Pharmacist Services Act -Older Americans Act

-Implementation of Medicare Part D beneficiary affordability provisions -Nursing home quality measures -Implementation of the Medicare Direct Negotiation Program -Utilization management reform in Medicare -Increasing Medication Access for Seniors Act (H.R.6401)

-CDC's ACIP Vaccine Recommendations for Fall 2025 -Marketing practices on telehealth platforms -Impacts of IRA on Older Americans -Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R. 842)

-Layoffs at health agencies -Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R. 842) -Telehealth -Centers for Disease Control and Preventions Division for Heart Disease and Stroke Prevention (CDC/DHDSP) -Retirement and Disability Research Consortium (RDRC) program at SSA -Older Americans Act -National Advisory Council on Aging at NIH

-Layoffs at health agencies -Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R. 842) -Telehealth -Centers for Disease Control and Preventions Division for Heart Disease and Stroke Prevention (CDC/DHDSP) -Retirement and Disability Research Consortium (RDRC) program at SSA -Older Americans Act -National Advisory Council on Aging at NIH

-enhanced Premium Tax Credits (ePTCs) -S.3337 the Strategic Plan for Aging Act -Federal vaccine messaging -Impacts of IRA on Older Americans

-H.R. 485 Protecting Health Care for All Patients Act of 2023 -H.R.3008 - Drug Shortage Prevention Act of 2023 -On the creation of an executive branch Office of Caregiver Health -Rollout of 2024 Covid-19 vaccines -HR 2630, the Safe Step Act -H.R.8816 - American Medical Innovation and Investment Act of 2024 -Pharmacy benefit manager reform

-H.R. 485 Protecting Health Care for All Patients Act of 2023 -H.R.3008 - Drug Shortage Prevention Act of 2023 -Rollout of 2024 Covid-19 vaccines -HR 2630, the Safe Step Act -H.R.8816 - American Medical Innovation and Investment Act of 2024 -Pharmacy benefit manager reform

-H.R. 485 Protecting Health Care for All Patients Act of 2023 -S. 652/H.R. 2630 the Safe Step Act -S. 3702/H.R. 7165 Credit for Caring Act -National Cholesterol Education Month and LDL-C Awareness Day -FDA Advisory Committee Meeting of the Circulatory System Devices Panel of the Medical Devices Advisory Committee -Pharmacy benefit manager reform

-H.R. 485 Protecting Health Care for All Patients Act of 2023 -H.R.3008 - Drug Shortage Prevention Act of 2023 -Rollout of 2024 Covid-19 vaccines -HR 2630, the Safe Step Act -H.R.8816 - American Medical Innovation and Investment Act of 2024 -Pharmacy benefit manager reform

-H.R. 485 Protecting Health Care for All Patients Act of 2023 -H.R.3008 - Drug Shortage Prevention Act of 2023 -On the creation of an executive branch Office of Caregiver Health -Rollout of 2024 Covid-19 vaccines -HR 2630, the Safe Step Act -H.R.8816 - American Medical Innovation and Investment Act of 2024 -Pharmacy benefit manager reform

-H.R. 485 Protecting Health Care for All Patients Act of 2023 -Telehealth protections -HR 2630, the Safe Step Act -Pharmacy benefit manager reform -National Institutes of Health (NIH) BRAIN initiative

-H.R. 485 Protecting Health Care for All Patients Act of 2023 -Telehealth protections -HR 2630, the Safe Step Act -Pharmacy benefit manager reform -National Institutes of Health (NIH) BRAIN initiative

-H.R. 485 Protecting Health Care for All Patients Act of 2023 -S. 652/H.R. 2630 the Safe Step Act -S. 3702/H.R. 7165 Credit for Caring Act -National Cholesterol Education Month and LDL-C Awareness Day -FDA Advisory Committee Meeting of the Circulatory System Devices Panel of the Medical Devices Advisory Committee -Pharmacy benefit manager reform

-H.R. 485 Protecting Health Care for All Patients Act of 2023 -H.R.3008 - Drug Shortage Prevention Act of 2023 -On the creation of an executive branch Office of Caregiver Health -Rollout of 2024 Covid-19 vaccines -HR 2630, the Safe Step Act -H.R.8816 - American Medical Innovation and Investment Act of 2024 -Pharmacy benefit manager reform

-H.R. 485 Protecting Health Care for All Patients Act of 2023 -H.R.3008 - Drug Shortage Prevention Act of 2023 -Rollout of 2024 Covid-19 vaccines -HR 2630, the Safe Step Act -H.R.8816 - American Medical Innovation and Investment Act of 2024 -Pharmacy benefit manager reform

-H.R. 485 Protecting Health Care for All Patients Act of 2023 -H.R.3008 - Drug Shortage Prevention Act of 2023 -On the creation of an executive branch Office of Caregiver Health -Rollout of 2024 Covid-19 vaccines -HR 2630, the Safe Step Act -H.R.8816 - American Medical Innovation and Investment Act of 2024 -Pharmacy benefit manager reform

-H.R. 485 Protecting Health Care for All Patients Act of 2023 -H.R.3008 - Drug Shortage Prevention Act of 2023 -Rollout of 2024 Covid-19 vaccines -HR 2630, the Safe Step Act -H.R.8816 - American Medical Innovation and Investment Act of 2024 -Pharmacy benefit manager reform

-H.R. 485 Protecting Health Care for All Patients Act of 2023 -Telehealth protections -HR 2630, the Safe Step Act -Pharmacy benefit manager reform -National Institutes of Health (NIH) BRAIN initiative

-H.R. 485 Protecting Health Care for All Patients Act of 2023 -H.R.3008 - Drug Shortage Prevention Act of 2023 -On the creation of an executive branch Office of Caregiver Health -Rollout of 2024 Covid-19 vaccines -HR 2630, the Safe Step Act -H.R.8816 - American Medical Innovation and Investment Act of 2024 -Pharmacy benefit manager reform

-H.R. 485 Protecting Health Care for All Patients Act of 2023 -Telehealth protections -HR 2630, the Safe Step Act -Pharmacy benefit manager reform -National Institutes of Health (NIH) BRAIN initiative

-H.R. 485 Protecting Health Care for All Patients Act of 2023 -S. 652/H.R. 2630 the Safe Step Act -S. 3702/H.R. 7165 Credit for Caring Act -National Cholesterol Education Month and LDL-C Awareness Day -FDA Advisory Committee Meeting of the Circulatory System Devices Panel of the Medical Devices Advisory Committee -Pharmacy benefit manager reform

-H.R. 485 Protecting Health Care for All Patients Act of 2023 -H.R.3008 - Drug Shortage Prevention Act of 2023 -On the creation of an executive branch Office of Caregiver Health -Rollout of 2024 Covid-19 vaccines -HR 2630, the Safe Step Act -H.R.8816 - American Medical Innovation and Investment Act of 2024 -Pharmacy benefit manager reform

-H.R. 485 Protecting Health Care for All Patients Act of 2023 -H.R.3008 - Drug Shortage Prevention Act of 2023 -Rollout of 2024 Covid-19 vaccines -HR 2630, the Safe Step Act -H.R.8816 - American Medical Innovation and Investment Act of 2024 -Pharmacy benefit manager reform

-H.R. 485 Protecting Health Care for All Patients Act of 2023 -S. 652/H.R. 2630 the Safe Step Act -S. 3702/H.R. 7165 Credit for Caring Act -National Cholesterol Education Month and LDL-C Awareness Day -FDA Advisory Committee Meeting of the Circulatory System Devices Panel of the Medical Devices Advisory Committee -Pharmacy benefit manager reform

-H.R. 485 Protecting Health Care for All Patients Act of 2023 -H.R.3008 - Drug Shortage Prevention Act of 2023 -Rollout of 2024 Covid-19 vaccines -HR 2630, the Safe Step Act -H.R.8816 - American Medical Innovation and Investment Act of 2024 -Pharmacy benefit manager reform

-H.R. 485 Protecting Health Care for All Patients Act of 2023 -S. 652/H.R. 2630 the Safe Step Act -S. 3702/H.R. 7165 Credit for Caring Act -National Cholesterol Education Month and LDL-C Awareness Day -FDA Advisory Committee Meeting of the Circulatory System Devices Panel of the Medical Devices Advisory Committee -Pharmacy benefit manager reform

-H.R. 485 Protecting Health Care for All Patients Act of 2023 -S. 652/H.R. 2630 the Safe Step Act -S. 3702/H.R. 7165 Credit for Caring Act -National Cholesterol Education Month and LDL-C Awareness Day -FDA Advisory Committee Meeting of the Circulatory System Devices Panel of the Medical Devices Advisory Committee -Pharmacy benefit manager reform

-H.R. 485 Protecting Health Care for All Patients Act of 2023 -H.R.3008 - Drug Shortage Prevention Act of 2023 -Rollout of 2024 Covid-19 vaccines -HR 2630, the Safe Step Act -H.R.8816 - American Medical Innovation and Investment Act of 2024 -Pharmacy benefit manager reform

-H.R. 485 Protecting Health Care for All Patients Act of 2023 -H.R.3008 - Drug Shortage Prevention Act of 2023 -Rollout of 2024 Covid-19 vaccines -HR 2630, the Safe Step Act -H.R.8816 - American Medical Innovation and Investment Act of 2024 -Pharmacy benefit manager reform

-H.R. 485 Protecting Health Care for All Patients Act of 2023 -H.R.3008 - Drug Shortage Prevention Act of 2023 -On the creation of an executive branch Office of Caregiver Health -Rollout of 2024 Covid-19 vaccines -HR 2630, the Safe Step Act -H.R.8816 - American Medical Innovation and Investment Act of 2024 -Pharmacy benefit manager reform

-H.R. 485 Protecting Health Care for All Patients Act of 2023 -H.R.3008 - Drug Shortage Prevention Act of 2023 -On the creation of an executive branch Office of Caregiver Health -Rollout of 2024 Covid-19 vaccines -HR 2630, the Safe Step Act -H.R.8816 - American Medical Innovation and Investment Act of 2024 -Pharmacy benefit manager reform

-Implementation of Medicare Part D beneficiary affordability provisions -Nursing home quality measures -S. 3109 the Alleviating Barriers for Caregivers Act -Implementation of the Medicare Direct Negotiation Program -Utilization management reform in Medicare -Medicare Advantage Advance Notice of Methodological Changes for Medicare Advantage (MA) Capitation Rates and Part C and D Payment Policies and Draft Calendar Year (CY) 2025 Part D Redesign Instructions

-Implementation of Medicare Part D beneficiary affordability provisions -Nursing home quality measures -S. 3109 the Alleviating Barriers for Caregivers Act -Implementation of the Medicare Direct Negotiation Program -Utilization management reform in Medicare -Medicare Advantage Advance Notice of Methodological Changes for Medicare Advantage (MA) Capitation Rates and Part C and D Payment Policies and Draft Calendar Year (CY) 2025 Part D Redesign Instructions

-H.R. 485 Protecting Health Care for All Patients Act of 2023 -S. 652/H.R. 2630 the Safe Step Act -S. 3702/H.R. 7165 Credit for Caring Act -National Cholesterol Education Month and LDL-C Awareness Day -FDA Advisory Committee Meeting of the Circulatory System Devices Panel of the Medical Devices Advisory Committee -Pharmacy benefit manager reform

-H.R. 485 Protecting Health Care for All Patients Act of 2023 -S. 652/H.R. 2630 the Safe Step Act -S. 3702/H.R. 7165 Credit for Caring Act -National Cholesterol Education Month and LDL-C Awareness Day -FDA Advisory Committee Meeting of the Circulatory System Devices Panel of the Medical Devices Advisory Committee -Pharmacy benefit manager reform

-H.R. 485 Protecting Health Care for All Patients Act of 2023 -S. 652/H.R. 2630 the Safe Step Act -S. 3702/H.R. 7165 Credit for Caring Act -National Cholesterol Education Month and LDL-C Awareness Day -FDA Advisory Committee Meeting of the Circulatory System Devices Panel of the Medical Devices Advisory Committee -Pharmacy benefit manager reform

-H.R. 485 Protecting Health Care for All Patients Act of 2023 -S. 652/H.R. 2630 the Safe Step Act -S. 3702/H.R. 7165 Credit for Caring Act -National Cholesterol Education Month and LDL-C Awareness Day -FDA Advisory Committee Meeting of the Circulatory System Devices Panel of the Medical Devices Advisory Committee -Pharmacy benefit manager reform

-H.R. 485 Protecting Health Care for All Patients Act of 2023 -National Cholesterol Education Month and LDL-C Awareness Day -CDC on Advisory Committee on Immunizations Practices' four open seats for medical professionals -H.R. 5074 the Kidney PATIENT Act of 2023 -Office of Civil Rights updates to section 504 of the Rehabilitation Act -S. 1001/H.R. 1843 the Telehealth Expansion Act of 2023 -S. 652/H.R. 2630 the Safe Step Act -S. 1339 the Pharmacy Benefit Manager Reform Act -H.R. 6284/S. 3260 the Improving Measurements for Loneliness and Isolation Act

Supported the SALSA Act (H.R. 2377 / S. 1000 to stop Congressional cuts to clinical laboratories

-H.R. 485 Protecting Health Care for All Patients Act of 2023 -National Cholesterol Education Month and LDL-C Awareness Day -CDC on Advisory Committee on Immunizations Practices' four open seats for medical professionals -H.R. 5074 the Kidney PATIENT Act of 2023 -Office of Civil Rights updates to section 504 of the Rehabilitation Act -S. 1001/H.R. 1843 the Telehealth Expansion Act of 2023 -S. 652/H.R. 2630 the Safe Step Act -S. 1339 the Pharmacy Benefit Manager Reform Act -H.R. 6284/S. 3260 the Improving Measurements for Loneliness and Isolation Act

-H.R. 485 Protecting Health Care for All Patients Act of 2023 -National Cholesterol Education Month and LDL-C Awareness Day -CDC on Advisory Committee on Immunizations Practices' four open seats for medical professionals -H.R. 5074 the Kidney PATIENT Act of 2023 -Office of Civil Rights updates to section 504 of the Rehabilitation Act -S. 1001/H.R. 1843 the Telehealth Expansion Act of 2023 -S. 652/H.R. 2630 the Safe Step Act -S. 1339 the Pharmacy Benefit Manager Reform Act -H.R. 6284/S. 3260 the Improving Measurements for Loneliness and Isolation Act

-H.R. 485 Protecting Health Care for All Patients Act of 2023 -FDA on status of safe and effective decongestants -HHS on health disparity populations -Food and Drug Administration's Patient-Focused Drug Development Series

-Increased federal funding for the Neurology Drug Program at the Food and Drug Administration -For H.R. 485 Protecting Health Care for All Patients Act of 2023, in support of a full federal ban on the use of the Quality Adjusted Life Year -Increased federal funding for the Brain Research Through Advancing Innovative Neurotechnologies (BRAIN) Initiative in FY 2024 -Increase federal funding for domestic and global antimicrobial resistance programs -Vaccine access

-For H.R. 485 Protecting Health Care for All Patients Act of 2023, in support of a full federal ban on the use of the Quality Adjusted Life Year -Increase federal funding for domestic and global antimicrobial resistance programs -In support of the President's April 18 Executive Order that advances policies that provide resources to family caregivers and advocate for more federal resources to better support them -In support of the United State's Preventative Services Task Force's effort to reevaluate pharmaceutical interventions for obesity

-H.R. 485 Protecting Health Care for All Patients Act of 2023 -National Cholesterol Education Month and LDL-C Awareness Day -CDC on Advisory Committee on Immunizations Practices' four open seats for medical professionals -H.R. 5074 the Kidney PATIENT Act of 2023 -Office of Civil Rights updates to section 504 of the Rehabilitation Act -S. 1001/H.R. 1843 the Telehealth Expansion Act of 2023 -S. 652/H.R. 2630 the Safe Step Act -S. 1339 the Pharmacy Benefit Manager Reform Act -H.R. 6284/S. 3260 the Improving Measurements for Loneliness and Isolation Act

-H.R. 485 Protecting Health Care for All Patients Act of 2023 -National Cholesterol Education Month and LDL-C Awareness Day -CDC on Advisory Committee on Immunizations Practices' four open seats for medical professionals -H.R. 5074 the Kidney PATIENT Act of 2023 -Office of Civil Rights updates to section 504 of the Rehabilitation Act -S. 1001/H.R. 1843 the Telehealth Expansion Act of 2023 -S. 652/H.R. 2630 the Safe Step Act -S. 1339 the Pharmacy Benefit Manager Reform Act -H.R. 6284/S. 3260 the Improving Measurements for Loneliness and Isolation Act

Supported the SALSA Act (H.R. 2377 / S. 1000 to stop Congressional cuts to clinical laboratories

-H.R. 485 Protecting Health Care for All Patients Act of 2023 -National Cholesterol Education Month and LDL-C Awareness Day -CDC on Advisory Committee on Immunizations Practices' four open seats for medical professionals -H.R. 5074 the Kidney PATIENT Act of 2023 -Office of Civil Rights updates to section 504 of the Rehabilitation Act -S. 1001/H.R. 1843 the Telehealth Expansion Act of 2023 -S. 652/H.R. 2630 the Safe Step Act -S. 1339 the Pharmacy Benefit Manager Reform Act -H.R. 6284/S. 3260 the Improving Measurements for Loneliness and Isolation Act

-H.R. 485 Protecting Health Care for All Patients Act of 2023 -National Cholesterol Education Month and LDL-C Awareness Day -CDC on Advisory Committee on Immunizations Practices' four open seats for medical professionals -H.R. 5074 the Kidney PATIENT Act of 2023 -Office of Civil Rights updates to section 504 of the Rehabilitation Act -S. 1001/H.R. 1843 the Telehealth Expansion Act of 2023 -S. 652/H.R. 2630 the Safe Step Act -S. 1339 the Pharmacy Benefit Manager Reform Act -H.R. 6284/S. 3260 the Improving Measurements for Loneliness and Isolation Act

-Lobbied for patient focused approach to the implementation of the Inflation Reduction Act's provisions for an out of pocket cap of $2000 for Medicare beneficiaries and the smoothing of costs for that population -Responded to the Agency's proposed guidance on the direct negotiation provision of the Inflation Reduction Act, advocating for them to avoid using discriminatory metrics like QALYs during the price setting process and asking them to ensure patients were included in those discussions -Responded to an HCPM guidance for implementation of the Part D provisions in the inflation reduction act advocating for patients to have continued access to therapies and for the program to monitor any impacts of direct negotiation on access, as well as recommending best practices for smoothing implementation -Lobbied Congress to have Medicare to create a complimentary measure for their current long-stay antipsychotic measure -Support S. 1544, which directs Medicare to expand access to PET radiopharmaceuticals -Lobbying on Medicare's Alzheimer's disease national coverage determination

-Implementation of Medicare Part D beneficiary affordability provisions -Stakeholder input in the Medicare drug price negotiation process -AP quality measure on antipsychotics for long-term stay in secure nursing facilities -S. 3109 the Alleviating Barriers for Caregivers Act -Implementation of the Medicare Direct Negotiation Program -Implementation of Medicare Prescription Payment Plan -Utilization management reform in Medicare

-H.R. 485 Protecting Health Care for All Patients Act of 2023 -National Cholesterol Education Month and LDL-C Awareness Day -CDC on Advisory Committee on Immunizations Practices' four open seats for medical professionals -H.R. 5074 the Kidney PATIENT Act of 2023 -Office of Civil Rights updates to section 504 of the Rehabilitation Act -S. 1001/H.R. 1843 the Telehealth Expansion Act of 2023 -S. 652/H.R. 2630 the Safe Step Act -S. 1339 the Pharmacy Benefit Manager Reform Act -H.R. 6284/S. 3260 the Improving Measurements for Loneliness and Isolation Act

-H.R. 485 Protecting Health Care for All Patients Act of 2023 -National Cholesterol Education Month and LDL-C Awareness Day -CDC on Advisory Committee on Immunizations Practices' four open seats for medical professionals -H.R. 5074 the Kidney PATIENT Act of 2023 -Office of Civil Rights updates to section 504 of the Rehabilitation Act -S. 1001/H.R. 1843 the Telehealth Expansion Act of 2023 -S. 652/H.R. 2630 the Safe Step Act -S. 1339 the Pharmacy Benefit Manager Reform Act -H.R. 6284/S. 3260 the Improving Measurements for Loneliness and Isolation Act

-FDA continue focus on COVID-19 prevention and treatment options -Patient access to next generation therapeutics to fight COVID-19 -Planning and content of the National Institute on Aging's Research Summit -Support the PASTUER Act (H.R. 3932)

-Held meetings and submitted letters on prescription drug pricing reform recommendations including measures to enhance affordability (Build Back Better, Senate Finance Sec. 129201 and 129202, Innovation Center demonstration projects), limiting out-of-pocket expenses for beneficiaries, moderating annual increases in drug prices, restructuring the cost-sharing, expanding Medicare services to include dental, hearing, and vision, and recommended a federal ban on the quality-adjusted life year (H.R. 5376) -Held meetings with CMS on implementation of a smoothing mechanism for Medicare Part D beneficiaries (H.R. 5376) -CMS end the coverage limit of one lifetime beta amyloid PET scan and provide national coverage for diagnostic evaluation and assessment to start or continue an Alzheimer's therapeutic -Improve Medicare Advantage plans by implementing patient centered utilization and pricing reforms -CMS'proposedrule updating Medicarepaymentand refining policies under the Physician Fee Schedule (PFS) (the Proposed Rule) to include the Fracture Liaison Service (FLS) -Section 139402 (provide first-dollar coverage of adult vaccines recommended by the Advisory Committee on Immunization Practices under Medicare Part D) and Section 139405 (improve access to adult vaccines under Medicaid and CHIP by providing a federal baseline for first-dollar coverage and an enhanced FMAP for immunizing providers.) of the Build Back Better Act. -Revision of CMS quality measure in order to appropriately measure clinically appropriate use of antipsychotic medications in nursing facilities

-Establishing a Neuroscience Center of Excellence within the FDA -H.R. 6000 Cures 2.0 Act -FDA clinical trial diversity -Patient-centered outcomes research principles with ARHQ

-Congress to pass S. 4449 / H.R. 8188 the Saving Access to Laboratory Services Act -AHRQ on clinical trial design criteria for Coverage with Evidence Development

-Encourage CDC to ensure patient access to pneumonia vaccines -Support H.R. 9310 The Preventative Services Early Action Act

-Congress to pass S. 4449 / H.R. 8188 the Saving Access to Laboratory Services Act -AHRQ on clinical trial design criteria for Coverage with Evidence Development